Influence of agglomeration and specific lung lining lipid/protein interaction on short-term inhalation toxicity

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nanotoxicology

• Publication date

  2016-03-17

• Fields of study

  Medicine, Materials Science, Chemistry, Environmental Science

• Identifiers
  DOI 10.3109/17435390.2016.1155671PMID 26984182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.

  2015cited by this paper
• Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles.

  2014cited by this paper
• Estimating the effective density of engineered nanomaterials for in vitro dosimetry

  2014cited by this paper
• As-Produced: Intrinsic Physico-Chemical Properties and Appropriate Characterization Tools

  2014cited by this paper
• Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials

  2014influential reference
• Analyzing the Biological Entity of Nanomaterials: Characterization of Nanomaterial Properties in Biological Matrices

  2014cited by this paper
• Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling.

  2014influential reference
• Safety of Nanomaterials along Their Lifecycle : Release, Exposure, and Human Hazards

  2014cited by this paper
• UniProt: a hub for protein information

  2014cited by this paper
• Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.

  2013cited by this paper
• Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles

  2013cited by this paper
• Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.

  2013cited by this paper
• Pulmonary surfactant is indispensable in order to simulate the in vivo situation

  2013cited by this paper
• Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges

  2013cited by this paper
• Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

  2013cited by this paper
• Adsorption and disruption of lipid bilayers by nanoscale protein aggregates.

  2012cited by this paper
• Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.

  2012cited by this paper
• Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies

  2012influential reference
• Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells.

  2012cited by this paper
• Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions.

  2012cited by this paper
• A study on the interaction of nanoparticles with lipid membranes and their influence on membrane fluidity

  2012cited by this paper
• Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats

  2012cited by this paper
• The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles

  2012influential reference
• Toward a molecular understanding of nanoparticle–protein interactions

  2012cited by this paper
• Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas

  2012cited by this paper
• Use of confocal microscopy for nanoparticle drug delivery through skin

  2012cited by this paper
• Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration.

  2012cited by this paper
• Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.

  2011cited by this paper
• Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes.

  2011influential reference
• What the cell "sees" in bionanoscience.

  2010cited by this paper
• Structural degradation at the surface of a TiO(2)-based nanomaterial used in cosmetics.

  2010cited by this paper
• Characterisation of nanoparticle size and state prior to nanotoxicological studies

  2010cited by this paper
• Characterization of nanomaterials for toxicity assessment.

  2009cited by this paper
• Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies

  2009influential reference
• Complete high‐density lipoproteins in nanoparticle corona

  2009cited by this paper
• Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

  2008cited by this paper
• Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.

  2008cited by this paper
• Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.

  2008cited by this paper
• How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?

  2008cited by this paper
• The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro.

  2007cited by this paper
• Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies

  2007cited by this paper
• Toxic Potential of Materials at the Nanolevel

  2006cited by this paper
• Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.

  2006cited by this paper
• Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

  2005cited by this paper
• Hydroxyl radical generation by electron paramagnetic resonance as a new method to monitor ambient particulate matter composition.

  2003cited by this paper
• Experimental Determination of Ultrafine TiO 2 Deagglomeration in a Surrogate Pulmonary Surfactant: Preliminary Results

  2002cited by this paper
• Detecting proteins separated by 2-D gel electrophoresis.

  2000cited by this paper
• Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

  2000cited by this paper
• Pulmonary surfactant: functions and molecular composition.

  1998influential reference
• Surfactant protein composition of lamellar bodies isolated from rat lung.

  1991cited by this paper
• Purification of surfactant from lung washings and washings contaminated with blood constituents

  1977cited by this paper
• The pulmonary surfactant.

  1972influential reference
• Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

  1970influential reference
• Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots

  1970influential reference

• Intratracheal Administration of Nanoplastics With Varying Surface Hydrophobicity Results in Coarsely Vacuolated Alveolar Macrophages, Transient Respiratory Inflammation, and Mild Collagen Deposition

  2025cites this paper
• The biomolecule corona mediates pulmonary delivery of nanomedicine.

  2024cites this paper
• Distinguishing Protein Corona from Nanoparticle Aggregate Formation in Complex Biological Media Using X-ray Photon Correlation Spectroscopy

  2024cites this paper
• Assessing inorganic nanoparticle toxicity through omics approaches.

  2024cites this paper
• Multiparametric in vitro genotoxicity assessment of different variants of amorphous silica nanomaterials in rat alveolar epithelial cells

  2023cites this paper
• Assessing the in vitro toxicity of airborne (nano)particles to the human respiratory system: from basic to advanced models

  2023cites this paper
• Pulmonary Surfactant Homeostasis Dysfunction Mediates Multiwalled Carbon Nanotubes Induced Lung Fibrosis via Elevating Surface Tension.

  2023cites this paper
• Colloidal stability and degradability of silica nanoparticles in biological fluids: a review

  2022cites this paper
• Sol-gel transition induced by alumina nanoparticles in a model pulmonary surfactant

  2022cites this paper
• Iron oxide nanoparticles oxidize transformed RAW 264.7 macrophages into foam cells: Impact of pulmonary surfactant component dipalmitoylphosphatidylcholine.

  2022cites this paper
• An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials.

  2022cites this paper
• Hepatic distribution and toxicity of zirconia nanoparticles in vivo and in vitro

  2021cites this paper
• Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants

  2021cites this paper
• Pulmonary surfactant as a versatile biomaterial to fight COVID-19

  2021cites this paper
• Polyhexamethylene guanidine aerosol triggers pulmonary fibrosis concomitant with elevated surface tension via inhibiting pulmonary surfactant.

  2021cites this paper
• Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation

  2021cites this paper
• Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver

  2021cites this paper
• Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant

  2021influential citation
• Understanding the interactions between inorganic-based nanomaterials and biological membranes.

  2021cites this paper
• The Use of Nanomaterial In Vivo Organ Burden Data for In Vitro Dose Setting.

  2021cites this paper
• Systematic Analysis of Composition, Interfacial Performance and Effects of Pulmonary Surfactant Preparations on Cellular Uptake and Cytotoxicity of Aerosolized Nanomaterials

  2021cites this paper
• Thermosensitive liposomes encapsulating hypericin: Characterization and photodynamic efficiency.

  2021cites this paper
• Analytical Centrifugation

  2020cites this paper
• Advanced In Vitro Testing Strategies and Models of the Intestine for Nanosafety Research.

  2020cites this paper
• Revealing the pulmonary surfactant corona on silica nanoparticles by cryo-transmission electron microscopy

  2020cites this paper
• The influence of shape and charge on protein corona composition in common gold nanostructures.

  2020cites this paper
• Toxicity of Zirconia oxide Nanoparticles: Liver Biodistribution and Liver Damages

  2020cites this paper
• Dosimetry in vitro – exploring the sensitivity of deposited dose predictions vs. affinity, polydispersity, freeze-thawing, and analytical methods

  2020cites this paper
• Evaluation of potential engineered nanomaterials impacts on human health: from risk for workers to impact on consumers

  2019cites this paper
• Culturability, metabolic activity and composition of ambient bacterial aerosols in a surrogate lung fluid.

  2019cites this paper
• In Vivo Inhalation Toxicity Screening Methods for Manufactured Nanomaterials

  2019cites this paper
• The Short-Term Inhalation Study (STIS) as a Range Finder and Screening Tool in a Tiered Grouping Strategy

  2019cites this paper
• The nanoGRAVUR framework to group (nano)materials for their occupational, consumer, environmental risks based on a harmonized set of material properties, applied to 34 case studies.

  2019cites this paper
• The Lord of the Lungs: the essential role of pulmonary surfactant upon inhalation of nanoparticles.

  2019cites this paper
• An in-depth multi-omics analysis in RLE-6TN rat alveolar epithelial cells allows for nanomaterial categorization

  2019cites this paper
• Time-resolved characterization of the mechanisms of toxicity induced by silica and amino-modified polystyrene on alveolar-like macrophages

  2019cites this paper
• Comparison of Tanaka lipid mixture with natural surfactant Alveofact to study nanoparticle interactions on Langmuir film balance.

  2019cites this paper
• Computational Investigations of the Interaction between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

  2018cites this paper
• Abiotic dissolution rates of 24 (nano)forms of 6 substances compared to macrophage-assisted dissolution and in vivo pulmonary clearance: Grouping by biodissolution and transformation

  2018cites this paper
• Combination of micro X-ray fluorescence spectroscopy and time-of-flight secondary ion mass spectrometry imaging for the marker-free detection of CeO2 nanoparticles in tissue sections

  2018cites this paper
• Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme

  2018cites this paper
• In Vitro and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO2

  2018cites this paper
• Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics

  2018cites this paper
• Nanoparticle-Lipid Interaction: Job Scattering Plots to Differentiate Vesicle Aggregation from Supported Lipid Bilayer Formation

  2018cites this paper
• Nanoparticle Wettability Influences Nanoparticle-Phospholipid Interactions.

  2018cites this paper
• Nanoparticle-Lipid Interaction: Job Scattering Plots to Differentiate Vesicle Aggregationfrom Supported Lipid Bilayer Formation

  2018cites this paper
• Distribution of Paramagnetic Fe2O3/SiO2–Core/Shell Nanoparticles in the Rat Lung Studied by Time-of-Flight Secondary Ion Mass Spectrometry: No Indication for Rapid Lipid Adsorption

  2018cites this paper
• The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants.

  2018cites this paper
• Phosphonate coating of SiO2 nanoparticles abrogates inflammatory effects and local changes of the lipid composition in the rat lung: a complementary bioimaging study

  2018cites this paper
• Toxicity screening of a novel poly(methylmethacrylate)-Eudragit nanocarrier on L929 fibroblasts.

  2017cites this paper
• Detection of SiO2 nanoparticles in lung tissue by ToF-SIMS imaging and fluorescence microscopy.

  2017cites this paper
• Nanomaterials: certain aspects of application, risk assessment and risk communication

  2017cites this paper
• In vitro approaches to assess the hazard of nanomaterials

  2017influential citation
• Cell and tissue-based in vitro models for improving the development of oral inhalation drug products.

  2017cites this paper
• Supported pulmonary surfactant bilayers on silica nanoparticles: formulation, stability and impact on lung epithelial cells.

  2017cites this paper
• A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition

  2017cites this paper
• Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes

  2017influential citation
• Role of omics techniques in the toxicity testing of nanoparticles

  2017cites this paper
• Risk Assessment and Risk Management

  2017cites this paper
• Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes

  2017influential citation
• Comparative short-term inhalation toxicity of five organic diketopyrrolopyrrole pigments and two inorganic iron-oxide-based pigments

  2016cites this paper
• The interaction of an amino-modified ZrO2 nanomaterial with macrophages—an in situ investigation by Raman microspectroscopy

  2016influential citation
• Interactions between DPPC as a component of lung surfactant and amorphous silica nanoparticles investigated by HILIC-ESI-MS.

  2016cites this paper
• The role of natural processes and surface energy of inhaled engineered nanoparticles on aggregation and corona formation.

  2016cites this paper
• The nanoparticle corona in the deep lung : pulmonary surfactant adsorption and its role in nano-bio interactions

  2016cites this paper